Renaissance Technologies’s TELA Bio TELA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$43.6K Buy
58,100
+5,500
+10% +$4.5K ﹤0.01% 3057
2026
Q1
$32.6K Sell
52,600
-76,100
-59% -$66.1K ﹤0.01% 3135
2025
Q4
$152K Buy
128,700
+64,800
+101% +$82K ﹤0.01% 2935
2025
Q3
$95.2K Sell
63,900
-3,433
-5% -$6.05K ﹤0.01% 3259
2025
Q2
$131K Sell
67,333
-177,111
-72% -$232K ﹤0.01% 3258
2025
Q1
$298K Sell
244,444
-180,696
-43% -$444K ﹤0.01% 2927
2024
Q4
$1.28M Buy
425,140
+276,240
+186% +$777K ﹤0.01% 2338
2024
Q3
$377K Buy
148,900
+70,600
+90% +$251K ﹤0.01% 2897
2024
Q2
$368K Buy
+78,300
New +$413K ﹤0.01% 2827
2024
Q1
Sell
-10,200
Closed -$68K 4071
2023
Q4
$68K Sell
10,200
-23,900
-70% -$138K ﹤0.01% 3394
2023
Q3
$273K Sell
34,100
-12,900
-27% -$120K ﹤0.01% 2977
2023
Q2
$476K Sell
47,000
-22,700
-33% -$232K ﹤0.01% 2894
2023
Q1
$742K Buy
69,700
+968
+1% +$10.7K ﹤0.01% 2662
2022
Q4
$790K Sell
68,732
-1,268
-2% -$11.4K ﹤0.01% 2670
2022
Q3
$596K Buy
70,000
+58,100
+488% +$482K ﹤0.01% 2821
2022
Q2
$83K Buy
+11,900
New +$98.8K ﹤0.01% 3892
2022
Q1
Sell
-10,521
Closed -$135K 4454
2021
Q4
$135K Sell
10,521
-17,679
-63% -$224K ﹤0.01% 3627
2021
Q3
$385K Sell
28,200
-17,400
-38% -$243K ﹤0.01% 2993
2021
Q2
$735K Buy
45,600
+16,600
+57% +$228K ﹤0.01% 2801
2021
Q1
$432K Buy
+29,000
New +$437K ﹤0.01% 2964

Other funds holding TELA

Renaissance Technologies's TELA Position: Q2 2026 in Review

Renaissance Technologies increased its TELA Bio (TELA) stake by 10% in Q2 2026, buying an estimated $4.5K and bringing the position to 58,100 shares worth $43.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3057.

Renaissance Technologies first reported a position in TELA in Q1 2021 and has held it in 20 quarters since. The position peaked at $1.28M in Q4 2024. 45 funds tracked by Wall St. Rank hold TELA as of Q2 2026.

  • Renaissance Technologies held 58,100 shares of TELA Bio worth $43.6K as of Q2 2026.
  • Renaissance Technologies bought 5,500 TELA Bio shares in Q2 2026, an estimated $4.5K.
  • TELA Bio made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #3057 holding.
  • Renaissance Technologies first reported a position in TELA Bio in Q1 2021 and has held it in 20 quarters since.
  • Renaissance Technologies's TELA Bio position peaked at $1.28M in Q4 2024.
  • 45 funds tracked by Wall St. Rank held TELA Bio as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.